Clinical trial
Evaluate the Acute Effects of a Single Oral Dose of TPN171H on Semen Function in Healthy Male Subjects in China
NCT05585931 is registered in ClinicalTrials.gov with Vigonvita Life Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluate the Acute Effects of a Single Oral Dose of TPN171H on Semen Function in Healthy Male Subjects in China
- Lead sponsor
- Vigonvita Life Sciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 15, 2022
- Completion date
- December 16, 2022
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.